Critical residues of epitopes recognized by several anti-p53 monoclonal antibodies correspond to key residues of p53 involved in interactions with the mdm2 protein

被引:8
作者
Portefaix, JM
Thebault, S
Bourgain-Guglielmetti, F
Del Rio, M
Granier, C
Mani, JC
Navarro-Teulon, I
Nicolas, M
Soussi, T
Pau, B
机构
[1] CRLC Val Daurelle, CNRS, UMR 5094, F-34298 Montpellier 5, France
[2] Inst Curie, CNRS, UMR 218, F-75231 Paris 5, France
关键词
p53; mdm2; monoclonal antibody; spot; surface plasmon resonance;
D O I
10.1016/S0022-1759(00)00246-5
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The aim of this work was to study the reactivity of antibodies directed against the N-terminus of p53 protein. First, we analysed the cross-reactivity of anti-p53 antibodies from human, mouse and rabbit sera with peptides derived from human, mouse and Xenopus p53. Next, we characterized more precisely a series of monoclonal antibodies directed against the N-terminal part of p53 and produced by immunizing mice with either full length human or Xenopus p53. For each of these mAbs we localized the epitope recognized on human p53 by the Spot method of multiple peptide synthesis, defined critical residues on p53 involved in the interaction by alanine scanning replacement experiments and determined kinetic parameters using real-time interaction analysis. These antibodies could be divided into two groups according to their epitopic and kinetic characteristics and their cross-reactivity with murine p53. Our results indicate that critical residues involved in the interaction of some of these mAbs with p53 correspond to key residues on p53 involved in its interaction with the mdm2 protein. These antibodies could, therefore, represent powerful tools for the study of p53 regulation. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:17 / 28
页数:12
相关论文
共 37 条
[1]   ISOLATION OF HUMAN-P53-SPECIFIC MONOCLONAL-ANTIBODIES AND THEIR USE IN THE STUDIES OF HUMAN P53 EXPRESSION [J].
BANKS, L ;
MATLASHEWSKI, G ;
CRAWFORD, L .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 159 (03) :529-534
[2]   IMMUNOHISTOCHEMICAL ANALYSIS OF THE P53 ONCOPROTEIN ON PARAFFIN SECTIONS USING A SERIES OF NOVEL MONOCLONAL-ANTIBODIES [J].
BARTEK, J ;
BARTKOVA, J ;
LUKAS, J ;
STASKOVA, Z ;
VOJTESEK, B ;
LANE, DP .
JOURNAL OF PATHOLOGY, 1993, 169 (01) :27-34
[3]   p53 and APC gene mutations: Software and databases [J].
Beroud, C ;
Soussi, T .
NUCLEIC ACIDS RESEARCH, 1997, 25 (01) :138-138
[4]   Regulation of the specific DNA binding activity of Xenopus laevis p53:: evidence for conserved regulation through the carboxy-terminus of the protein [J].
Bessard, ACH ;
Garay, E ;
Lacronique, V ;
Legros, Y ;
Demarquay, C ;
Houque, A ;
Portefaix, JM ;
Granier, C ;
Soussi, T .
ONCOGENE, 1998, 16 (07) :883-890
[5]   Two tandem and independent sub-activation domains in the amino terminus of p53 require the adaptor complex for activity [J].
Candau, R ;
Scolnick, DM ;
Darpino, P ;
Ying, CY ;
Halazonetis, TD ;
Berger, SL .
ONCOGENE, 1997, 15 (07) :807-816
[6]  
CANNON JV, 1990, EMBO J, V9, P1595
[7]   DETECTION OF ANTIBODIES AGAINST THE CELLULAR PROTEIN P53 IN SERA FROM PATIENTS WITH BREAST-CANCER [J].
CRAWFORD, LV ;
PIM, DC ;
BULBROOK, RD .
INTERNATIONAL JOURNAL OF CANCER, 1982, 30 (04) :403-408
[8]   PRESENCE OF CIRCULATING ANTIBODIES AGAINST CELLULAR PROTEIN P53 IN A NOTABLE PROPORTION OF CHILDREN WITH B-CELL LYMPHOMA [J].
DEFROMENTEL, CC ;
MAYLEVIN, F ;
MOURIESSE, H ;
LEMERLE, J ;
CHANDRASEKARAN, K ;
MAY, P .
INTERNATIONAL JOURNAL OF CANCER, 1987, 39 (02) :185-189
[9]  
DOWELL SP, 1994, CANCER RES, V54, P2914
[10]   Mimicry between receptors and antibodies - Identification of snake toxin determinants recognized by the acetylcholine receptor and an acetylcholine receptor-mimicking monoclonal antibody [J].
Ducancel, F ;
Merienne, K ;
FromenRomano, C ;
Tremeau, O ;
Pillet, L ;
Drevet, P ;
ZinnJustin, S ;
Boulain, JC ;
Menez, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (49) :31345-31353